Identifying the Prognostic Risk Factors of Synaptojanin 2 and Its Underlying Perturbations Pathways in Hepatocellular Carcinoma

by Rui Zhang, Wei-Jia Mo, Lan-Shan Huang, Ji-Tian Chen, Wei-Zi Wu, Wei-Ying He, Zhen-Bo Feng
Published 2021-01-01

Clinical significance and molecular mechanism of angiotensin-converting enzyme 2 in hepatocellular carcinoma tissues

by Wei-Jian Huang, Wei-Ying He, Jian-Di Li, Rong-Quan He, Zhi-Guang Huang, Xian-Guo Zhou, Jian-Jun Li, Da-Tong Zeng, Ji-Tian Chen, Wei-Zi Wu, Yi-Wu Dang, Gang Chen
Published 2021-01-01